Premier Biomedical Inc (BIEI) Return on Equity ROE from the fourth quarter 2019 to fourth quarter 2018 and annually, average high and low, overall ranking from Dec 31 2019 to Dec 31 2018 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Premier Biomedical Inc  (BIEI)

Premier Biomedical Inc's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Premier Biomedical Inc in the fourth quarter 2019?
Due to the lack of equity, it was not possible to calculate Premier Biomedical Inc's return on equity (ROE) in its fourth quarter 2019

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Dec 31 2019)
IV. Quarter		 (Sep 30 2019)
III. Quarter		 (Jun 30 2019)
II. Quarter		 (Mar 31 2019)
I. Quarter		 (Dec 31 2018)
IV. Quarter
Y / Y Equity Change - - - - -
Y / Y Net Income Change - - - -87.9 % -
Net Income (TTM) in Millions 0 -1 -1 -1 0
Return On Equity (TTM) - - - - -
BIEI's Total Ranking # # # # #
Equity (TTM) in Millions -2 -2 -2 -2 -2
Seq. Equity Change - - - - -
Seq. Net Income Change - - - - -

Back to BIEI Management Effectiveness >> BIEI's 5 Years Annual ROE >> Compare BIEI ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry #
Sector #
Overall #

Return On Equity Statistics
High Average Low
0 %
0 %
0 %
 





BIEI Annual Return On Equity (Dec 31 2019)
2019		 (Dec 31 2018)
2018		 (Dec 31 2017)
2017		 (Dec 31 2016)
2016		 (Dec 31 2015)
2015
Total Equity in Millions -2 -2 -3 -1 0
Y / Y Equity Change - - - - -
Net Income in Millions 0 0 -4 -2 -3
Y / Y Net Income Change - - - - -
Return On Equity - - - - -

Back to BIEI Management Effectiveness >> BIEI's 5 Years Annual ROE >> Compare BIEI ROE to its Competitors




More Return On Equity Ratios
Biotechnology & Pharmaceuticals Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
BIEI's' Return on Equity at Yahoo Finance
BIEI's Roe Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for BIEI's Competitors
Subscribers only: Roe for Premier Biomedical Inc's Suppliers
Subscribers only: Return On Equity for BIEI's Customers




Companies with similar Return On Equity at Dec 31 2019, within Healthcare Sector ROE
Purple Biotech Ltd  49.80 %
Palatin Technologies Inc   48.34 %
Cnbx Pharmaceuticals Inc   47.76 %
Catalyst Pharmaceuticals Inc   45.52 %
Opiant Pharmaceuticals Inc   45.08 %
3m Company  44.93 %
Boston Scientific Corporation  44.69 %
Biogen Inc   43.54 %
Lifevantage Corp  43.22 %
Remedent Inc   40.57 %
Merck and Co Inc   36.10 %
Arena Pharmaceuticals Inc   34.11 %
Horizon Therapeutics Public Limited Company  33.88 %
Chemed Corporation  33.76 %
Align Technology inc   33.54 %
Vanda Pharmaceuticals Inc   33.33 %
Bio rad Laboratories Inc   33.12 %
Lantheus Holdings Inc   32.38 %
Tenet Healthcare Corp  31.48 %
Davita Inc   31.04 %
Galmed Pharmaceuticals Ltd   29.35 %
Corcept Therapeutics Inc  29.22 %
Edwards Lifesciences Corporation  28.08 %
Gsk Plc  27.61 %
Encompass Health Corporation  27.16 %
Pfizer Inc  26.30 %
Johnson and Johnson  25.47 %
Abiomed Inc   24.65 %
U S Physical Therapy Inc  24.60 %
Gilead Sciences Inc   24.32 %

Date modified: 2026-09-08T15:09:57+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.